Neurocrine Biosciences, Inc (NBIX) Covered Calls

Neurocrine Biosciences, Inc covered calls Neurocrine Biosciences, Inc. discovers, develops and plans to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders.

You can sell covered calls on Neurocrine Biosciences, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NBIX (prices last updated Mon 4:16 PM ET):

Neurocrine Biosciences, Inc (NBIX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
80.08 +1.65 76.02 81.20 1.1M 357 7.1B
Covered Calls For Neurocrine Biosciences, Inc (NBIX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 80 4.60 76.60 4.4% 61.8%
Aug 16 80 8.90 72.30 10.7% 33.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.